NCT05697939

Brief Summary

This is a single center, prospective, non-randomized reproducibility study of the NSite device in patients undergoing evaluation for scoliosis. The NSite device is a pre-market, investigational device. The study will enroll 13 eligible patients, who will be scanned using the NSite device by 3 separate users in order to assess if the device generates similar results across users. This data will be used to support 510(k) submission.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for all trials

Timeline
45mo left

Started Aug 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Aug 2020Jan 2030

Study Start

First participant enrolled

August 26, 2020

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

January 14, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 26, 2023

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

April 16, 2025

Status Verified

March 1, 2025

Enrollment Period

9.4 years

First QC Date

January 14, 2023

Last Update Submit

April 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assess the reproducibility of NSite device

    Percentage of scan outputs reproducible. The percentage of scan sets (3 scans for each participant) that have reproducible predicted probabilities for major curve magnitude ≥ 20 degrees. A reproducible output will be defined as a scan set in which all scans have overlapping 95% confidence intervals for the predicted probability of major curve magnitude ≥ 20 degrees.

    Anticipated to take about one month in order to recruit, enroll, and scan 13 patients.

Secondary Outcomes (1)

  • User Feedback

    Anticipated to take about one month in order to recruit, enroll, and scan 13 patients.

Study Arms (1)

Adolescent Idiopathic Scoliosis

Reproducibility group

Diagnostic Test: NSite 3D Scanning

Interventions

NSite 3D ScanningDIAGNOSTIC_TEST

Three separate users will enter the exam room and use the NSite application to scan the patient in the bending position. These users may include research coordinators, physicians, or other authorized staff. The NSite application will have a user tutorial on how to scan patients that users are instructed to watch prior to conducting a scan. All participants are asked to remove clothing above the waist but may keep a bra or tight-fitting shirt on during the scanning procedures. The patient will be asked to assume a forward bending position. One user will capture a scan of the patient's back in this position. The user will calibrate the device and then walk around the patient while scanning per app directions. Once this user captures the scan, it will be processed by the application. New scans will then be obtained by the two other users. Once all users have captured a scan, the scanning process and patient participation will be completed.

Adolescent Idiopathic Scoliosis

Eligibility Criteria

Age10 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with adolescent idiopathic scoliosis, ages 10-18

You may qualify if:

  • Ages 10 and 18 years old
  • Referred for evaluation of or diagnosed of adolescent idiopathic scoliosis

You may not qualify if:

  • Scoliosis caused by another condition (e.g., secondary scoliosis)
  • Parents/guardians unable to consent
  • English is not the primary language (to avoid miscommunication)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lucille Packard Children's Hospital and Clinics

Palo Alto, California, 94304, United States

RECRUITING

Study Officials

  • Kali Tileston, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kali R Tileston, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor, Orthopaedic Surgery

Study Record Dates

First Submitted

January 14, 2023

First Posted

January 26, 2023

Study Start

August 26, 2020

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

January 1, 2030

Last Updated

April 16, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations